ロード中...

Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency (SCID) Patients: a Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT

Severe Combined Immunodeficiency (SCID) is one of the most common indications for pediatric hematopoietic cell transplantation (HCT) in patients with primary immunodeficiency (PID). Historically, SCID was diagnosed in infants who presented with opportunistic infections within the first year of life....

詳細記述

保存先:
書誌詳細
出版年:Biol Blood Marrow Transplant
主要な著者: Heimall, J, Puck, J, Buckley, R H, Fleisher, T A, Gennery, A R, Neven, B, Slatter, M, Haddad, E, Notarangelo, L, Baker, KS, Dietz, A C, Duncan, C, Pulsipher, M A, Cowan, MJ
フォーマット: Artigo
言語:Inglês
出版事項: 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5659271/
https://ncbi.nlm.nih.gov/pubmed/28068510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.12.619
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!